
Please try another search
Proteomics International Laboratories Ltd operates as a medical technology company with a focus on the area of proteomics in Australia, New Zealand, the United States, Europe, India, and South East Asia. It provides PromarkerD, a protein-based diagnostic blood test to predict diabetic kidney disease (DKD). The company’s products under development include PromarkerEndo, which has completed clinical validation phase for endometriosis diagnosis; PromarkerEso, that has completed clinical validation trials for esophageal cancer diagnosis; and OxiDx (2-tag), which has completed clinical validation phase for oxidative stress treatment. It is also developing diagnostic tests for that includes DKD - T1D, that is under clinical phase for diabetic kidney disease in type 1 diabetes; Asthma and COPD, which has completed proof-of-concept study trials for asthma and chronic obstructive pulmonary disease; Plant Dieback, that is under development phase for phytophthora dieback; Diabetic Retinopathy, which has completed discovery phase for sight-threatening retinopathy; Diabetic Neuropathy, that is under research phase to investigate predictive biomarkers for diabetic neuropathy; and Giardia, a causing gastroenteritis. The company also offers analytical services, such as pharmacokinetic testing, biomarker discovery, protein analysis, project consultation, and specialist contract research. Proteomics International Laboratories Ltd was founded in 2001 and is headquartered in Perth, Australia.
Name | Age | Since | Title |
---|---|---|---|
Terry Sweet | 74 | 2014 | Independent Non-Executive Chairman |
Merlin Thomas | - | 2022 | Member of Clinical Advisory Board |
Eleuterio Ferrannini | - | 2022 | Member of Clinical Advisory Board |
Michael Shanik | - | 2022 | Member of Clinical Advisory Board |
Alexander Turchin | - | 2022 | Member of Clinical Advisory Board |
Tim Davis | - | 2022 | Member of Clinical Advisory Board |
Davida F. Kruger | - | - | Member of Clinical Advisory Board |
James Williams | - | 2024 | Independent Non- Executive Director |
Paul House | 54 | 2017 | Independent Non-Executive Director |
Neville Gardiner | - | 2021 | Independent Non-Executive Director |
Richard John Lipscombe | - | 2001 | Co-Founder, MD & Director |
Aaron Brinkworth | - | 2024 | Independent Non-Executive Director |
Prasad Iyer | - | 2025 | Member of Clinical Advisory Board |
Andrew Chang | - | 2025 | Member of Clinical Advisory Board |
Krish Ragunath | - | 2025 | Member of Clinical Advisory Board |
Jacques Bergman | - | 2025 | Member of Clinical Advisory Board |
Robert Odze | - | 2025 | Member Clinical Advisory Board |
Daniela Molena | - | 2025 | Member of Clinical Advisory Board |
Hugh Barr | - | 2025 | Member of Clinical Advisory Board |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review